CI
RGEN icon

Clal Insurance’s Repligen RGEN Stock Holding History

Clal Insurance’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Sell
21
-38
-64% -$4.67K ﹤0.01% 218
2026
Q1 		$7K Buy
59
+19
+48% +$2.65K ﹤0.01% 197
2025
Q4 		$7K Sell
40
-42
-51% -$6.58K ﹤0.01% 203
2025
Q3 		$11K Buy
+82
New +$9.96K ﹤0.01% 193

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Clal Insurance's RGEN Position: Q2 2026 in Review

Clal Insurance reduced its Repligen (RGEN) stake by 64% in Q2 2026, selling an estimated $4.67K and leaving 21 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Clal Insurance first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. The position peaked at $11K in Q3 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Clal Insurance held 21 shares of Repligen worth $3K as of Q2 2026.
  • Clal Insurance sold 38 Repligen shares in Q2 2026, an estimated $4.67K.
  • Repligen made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #218 holding.
  • Clal Insurance first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • Clal Insurance's Repligen position peaked at $11K in Q3 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.